These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 15168797)

  • 1. Isolation and characterization of NMSO3-resistant mutants of respiratory syncytial virus.
    Kimura K; Ishioka K; Hashimoto K; Mori S; Suzutani T; Bowlin TL; Shigeta S
    Antiviral Res; 2004 Mar; 61(3):165-71. PubMed ID: 15168797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the inhibition of human metapneumovirus and respiratory syncytial virus by NMSO3 in tissue culture assays.
    Wyde PR; Moylett EH; Chetty SN; Jewell A; Bowlin TL; Piedra PA
    Antiviral Res; 2004 Jul; 63(1):51-9. PubMed ID: 15196820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. YM-53403, a unique anti-respiratory syncytial virus agent with a novel mechanism of action.
    Sudo K; Miyazaki Y; Kojima N; Kobayashi M; Suzuki H; Shintani M; Shimizu Y
    Antiviral Res; 2005 Feb; 65(2):125-31. PubMed ID: 15708639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral activity of NMSO3 against respiratory syncytial virus infection in vitro and in vivo.
    Kimura K; Mori S; Tomita K; Ohno K; Takahashi K; Shigeta S; Terada M
    Antiviral Res; 2000 Jul; 47(1):41-51. PubMed ID: 10930645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiviral activity of NMSO3 against adenovirus in vitro.
    Kaneko H; Kato K; Mori S; Shigeta S
    Antiviral Res; 2001 Dec; 52(3):281-8. PubMed ID: 11675145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular epidemiology of respiratory syncytial virus (RSV) of group A in Stockholm, Sweden, between 1965 and 2003.
    Rafiefard F; Johansson B; Tecle T; Orvell C
    Virus Res; 2004 Oct; 105(2):137-45. PubMed ID: 15351487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nosocomial outbreak of respiratory syncytial virus subgroup B variants with the 60 nucleotides-duplicated G protein gene.
    Nagai K; Kamasaki H; Kuroiwa Y; Okita L; Tsutsumi H
    J Med Virol; 2004 Sep; 74(1):161-5. PubMed ID: 15258983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conservation of the respiratory syncytial virus SH gene.
    Chen MD; Vazquez M; Buonocore L; Kahn JS
    J Infect Dis; 2000 Oct; 182(4):1228-33. PubMed ID: 10979923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polysulfated sialic acid derivatives as anti-human immunodeficiency virus.
    Terada M; Fujita S; Suda I; Mastico R
    Biomed Pharmacother; 2005 Sep; 59(8):423-9. PubMed ID: 16143490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of the M2-2 protein of respiratory syncytial virus inhibits viral replication.
    Cheng X; Park H; Zhou H; Jin H
    J Virol; 2005 Nov; 79(22):13943-52. PubMed ID: 16254330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variable resistance to palivizumab in cotton rats by respiratory syncytial virus mutants.
    Zhao X; Chen FP; Megaw AG; Sullender WM
    J Infect Dis; 2004 Dec; 190(11):1941-6. PubMed ID: 15529258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural polymorphisms and resistance-associated mutations in the fusion protein of respiratory syncytial virus (RSV): effects on RSV susceptibility to palivizumab.
    Zhu Q; Patel NK; McAuliffe JM; Zhu W; Wachter L; McCarthy MP; Suzich JA
    J Infect Dis; 2012 Feb; 205(4):635-8. PubMed ID: 22184728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiviral activity and mode of action of caffeoylquinic acids from Schefflera heptaphylla (L.) Frodin.
    Li Y; But PP; Ooi VE
    Antiviral Res; 2005 Oct; 68(1):1-9. PubMed ID: 16140400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel inhibitor of respiratory syncytial virus isolated from ethnobotanicals.
    Ojwang JO; Wang YH; Wyde PR; Fischer NH; Schuehly W; Appleman JR; Hinds S; Shimasaki CD
    Antiviral Res; 2005 Dec; 68(3):163-72. PubMed ID: 16280176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell fusion assay by expression of respiratory syncytial virus (RSV) fusion protein to analyze the mutation of palivizumab-resistant strains.
    Yasui Y; Yamaji Y; Sawada A; Ito T; Nakayama T
    J Virol Methods; 2016 May; 231():48-55. PubMed ID: 26794681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic variability of the fusion protein and circulation patterns of genotypes of the respiratory syncytial virus.
    Kim YK; Choi EH; Lee HJ
    J Med Virol; 2007 Jun; 79(6):820-8. PubMed ID: 17457915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance testing of two new one-step real time PCR assays for detection of human influenza and avian influenza viruses isolated in humans and respiratory syncytial virus.
    Valle L; Amicizia D; Bacilieri S; Banfi F; Riente R; Durando P; Sticchi L; Gasparini R; Esposito C; Icardi G; Ansaldi F
    J Prev Med Hyg; 2006 Dec; 47(4):127-33. PubMed ID: 17263157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanistic effect of NMSO3 on replication of human immunodeficiency virus.
    Nakamura M; Terada M; Kamada M; Yokono A; Nakamori S; Ohno T
    Antivir Chem Chemother; 2003 Jul; 14(4):171-6. PubMed ID: 14582845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of respiratory syncytial virus by RhoA-derived peptides: implications for the development of improved antiviral agents targeting heparin-binding viruses.
    Budge PJ; Graham BS
    J Antimicrob Chemother; 2004 Aug; 54(2):299-302. PubMed ID: 15254023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tiotropium bromide attenuates respiratory syncytial virus replication in epithelial cells.
    Iesato K; Tatsumi K; Saito K; Ogasawara T; Sakao S; Tada Y; Kasahara Y; Kurosu K; Tanabe N; Takiguchi Y; Kuriyama T; Shirasawa H
    Respiration; 2008; 76(4):434-41. PubMed ID: 18728351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.